Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its insulin 70% and said it will automatically cap out-of-pocket insulin costs at ...

Eli Lilly has announced that it will cap out-of-pocket costs for insulin at $35 a month. Its price of non-branded insulin will be reduced to $25 a vial. The cost of insulin Trusted Source has ...

Eli Lilly said it would cap the out-of-pocket cost of insulin at $35 per month. More than 8 million people with diabetes rely on insulin, which is notoriously expensive in the U.S.

Effective immediately, Lilly will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.

Eli Lilly and Company will cut the prices of its most-prescribed insulin by 70% and cap patient monthly out-of-pocket costs at $35 or less, the company announced Wednesday.

Lilly says it will also expand its Insulin Value Program, which caps out-of-pocket costs at $35 or less per month for people who are uninsured.

Eli Lilly will cut insulin prices, capping costs at $35 for many people with diabetes. Pictured are the glucometer, test strips, and insulin against the backdrop of record results.

Lilly says it will also expand its Insulin Value Program, which caps out-of-pocket costs at $35 or less per month for people who are uninsured.